Why Pharma’s Digital Health Tools Miss the Mark

03.19.26   |  

Originally published in Pharmaphorum, March 2026

Pharma has invested heavily in digital health over the past decade. Yet many tools struggle to move beyond pilots or sustain meaningful engagement.

The challenge isn’t innovation. It’s execution. When digital health initiatives operate outside brand strategy, clinical workflows, and clear value models, even well-designed solutions can lose relevance and stall.

In this latest perspective, we explore why these patterns persist and what leading organizations are doing differently—from aligning digital and brand teams to redefining ROI and designing solutions that fit real-world care pathways.

Read the article on Pharmaphorum, where digital health insiders share common traps to avoid and the lessons learned for success.

 

Read the full article.

 

Authors

Gregg Fisher, Managing Partner, The Stemgfisher@thestem.com

David Dixon is a Lead Digital Health Strategy Consultant, The Stem

Category: Digital Health, Digital Transformation, Featured blog post, Innovation, Pharmaceutical & Biotechnology

Tags: Artificial Intelligence, biopharma, digital health, digital innovation, digital transformation, life science

Return to articles page

follow us on LinkedIn

Next post

Agentic AI in Medical Affairs

Improve Medical Affairs Agility with AI,

Originally published in Pharmaphorum, March 2026   Medical Affairs is under increasing pressure to move faster while remaining scientifically rigorous, compliant, and customer-centric. Field insights are richer than ever, yet too often they move slowly through disconnected …

Stay Connected


Keep informed with our latest thought leadership and updates.

Email address is required Please enter valid email address
First name is required Please enter valid first name